NO20050279D0 - Ny fremgangsmate - Google Patents
Ny fremgangsmateInfo
- Publication number
- NO20050279D0 NO20050279D0 NO20050279A NO20050279A NO20050279D0 NO 20050279 D0 NO20050279 D0 NO 20050279D0 NO 20050279 A NO20050279 A NO 20050279A NO 20050279 A NO20050279 A NO 20050279A NO 20050279 D0 NO20050279 D0 NO 20050279D0
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- preparation
- serotonin
- prophylaxis
- new procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 5
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 4
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 229940076279 serotonin Drugs 0.000 abstract 2
- OGTLIDNRGOUIAQ-SSDOTTSWSA-N 2-chloro-3-[(2r)-2-methylpiperazin-1-yl]pyrazine Chemical compound C[C@@H]1CNCCN1C1=NC=CN=C1Cl OGTLIDNRGOUIAQ-SSDOTTSWSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Pyridine Compounds (AREA)
- Luminescent Compositions (AREA)
Abstract
Det beskrives en fremgangsmåte for fremstilling av forbindelser som er terapeutisk aktive i sentralnervesystemet. I et aspekt beskrives det en fremgangsmåte for fremstilling av forbindelser med den generelle formel (I). Oppfinnelsen angår også (2R)- 1-(3 -klor-2-pyrazinyl)-2-metylpiperazin, hydroklorid og en fremgangsmåte for fremstilling derav. Videre beskrives en forbindelse med formel (I). Forbindelsene som oppnås under anvendelse ved behandling eller profylakse av serotoninrelaterte lidelser og videre beskrives bruken av forbindelsene for fremstilling av medikamenter for profylakse eller terapi av serotoninrelaterte lidelser.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201881A SE0201881D0 (sv) | 2002-06-19 | 2002-06-19 | Novel compounds, their use, and preparation |
US39065602P | 2002-06-21 | 2002-06-21 | |
SE0202041A SE0202041D0 (sv) | 2002-06-28 | 2002-06-28 | Novel process |
US40611902P | 2002-08-26 | 2002-08-26 | |
SE0202516A SE0202516D0 (sv) | 2002-08-26 | 2002-08-26 | Novel compounds, their use, and preparation |
US41670102P | 2002-10-07 | 2002-10-07 | |
PCT/SE2003/001043 WO2004000829A1 (en) | 2002-06-19 | 2003-06-18 | Novel process |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050279D0 true NO20050279D0 (no) | 2005-01-18 |
Family
ID=30004077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050279A NO20050279D0 (no) | 2002-06-19 | 2005-01-18 | Ny fremgangsmate |
Country Status (16)
Country | Link |
---|---|
EP (2) | EP1529043B1 (no) |
JP (4) | JP4592417B2 (no) |
CN (1) | CN100334082C (no) |
AT (2) | ATE398119T1 (no) |
AU (1) | AU2003237746B8 (no) |
CA (1) | CA2485532C (no) |
CY (1) | CY1106225T1 (no) |
DE (2) | DE60307286T2 (no) |
DK (2) | DK1529043T3 (no) |
ES (2) | ES2270051T3 (no) |
HK (1) | HK1080079B (no) |
NO (1) | NO20050279D0 (no) |
NZ (1) | NZ536663A (no) |
PT (2) | PT1529043E (no) |
SI (2) | SI1645558T1 (no) |
WO (1) | WO2004000829A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1792629A4 (en) | 2004-08-25 | 2010-08-25 | Takeda Pharmaceutical | PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
JP5317354B2 (ja) | 2007-10-16 | 2013-10-16 | 第一三共株式会社 | ピリミジルインドリン化合物 |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
CA2765239C (en) | 2009-06-15 | 2018-08-07 | Takeda Pharmaceutical Company Limited | Pyrazinooxazepine derivatives |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
GB201304811D0 (en) * | 2013-03-15 | 2013-05-01 | Proximagen Ltd | Novel treatment for hypertension |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06306075A (ja) * | 1993-04-23 | 1994-11-01 | Sanwa Kagaku Kenkyusho Co Ltd | エトキシベンズアミド誘導体 |
CN1242995C (zh) * | 1999-05-21 | 2006-02-22 | 比奥维特罗姆股份公司 | 化合物,它们的用途和制备方法 |
AR032318A1 (es) * | 2000-04-13 | 2003-11-05 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa |
CN1227237C (zh) * | 2000-11-20 | 2005-11-16 | 比奥维特罗姆股份公司 | 作为五羟色胺5-ht2受体拮抗剂的哌嗪基吡嗪化合物 |
-
2003
- 2003-06-18 DE DE60307286T patent/DE60307286T2/de not_active Expired - Lifetime
- 2003-06-18 PT PT03736405T patent/PT1529043E/pt unknown
- 2003-06-18 EP EP03736405A patent/EP1529043B1/en not_active Expired - Lifetime
- 2003-06-18 PT PT05023471T patent/PT1645558E/pt unknown
- 2003-06-18 SI SI200331283T patent/SI1645558T1/sl unknown
- 2003-06-18 DE DE60321606T patent/DE60321606D1/de not_active Expired - Lifetime
- 2003-06-18 AT AT05023471T patent/ATE398119T1/de active
- 2003-06-18 ES ES03736405T patent/ES2270051T3/es not_active Expired - Lifetime
- 2003-06-18 ES ES05023471T patent/ES2307102T3/es not_active Expired - Lifetime
- 2003-06-18 CN CNB038141612A patent/CN100334082C/zh not_active Expired - Fee Related
- 2003-06-18 EP EP05023471A patent/EP1645558B1/en not_active Expired - Lifetime
- 2003-06-18 NZ NZ536663A patent/NZ536663A/en not_active IP Right Cessation
- 2003-06-18 AT AT03736405T patent/ATE334980T1/de active
- 2003-06-18 SI SI200330493T patent/SI1529043T1/sl unknown
- 2003-06-18 JP JP2004530934A patent/JP4592417B2/ja not_active Expired - Fee Related
- 2003-06-18 AU AU2003237746A patent/AU2003237746B8/en not_active Ceased
- 2003-06-18 DK DK03736405T patent/DK1529043T3/da active
- 2003-06-18 WO PCT/SE2003/001043 patent/WO2004000829A1/en active IP Right Grant
- 2003-06-18 CA CA2485532A patent/CA2485532C/en not_active Expired - Fee Related
- 2003-06-18 DK DK05023471T patent/DK1645558T3/da active
-
2005
- 2005-01-18 NO NO20050279A patent/NO20050279D0/no not_active Application Discontinuation
-
2006
- 2006-01-04 HK HK06100135.0A patent/HK1080079B/zh not_active IP Right Cessation
- 2006-10-30 CY CY20061101556T patent/CY1106225T1/el unknown
-
2010
- 2010-01-07 JP JP2010002229A patent/JP5378241B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-04 JP JP2013019444A patent/JP2013116906A/ja active Pending
- 2013-07-08 JP JP2013142942A patent/JP2013227336A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050279D0 (no) | Ny fremgangsmate | |
BR0310106A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica | |
NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
ATE381537T1 (de) | Formanilid-derivative als beta2-adrenorezeptor- agonisten | |
ATE365720T1 (de) | Agonisten von beta-adrenorezeptoren | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
HK1091121A1 (en) | Substituted 2-aminotetralins for the treatment of depressions | |
NO20060020L (no) | 3-fluorpiperidiner som NMDA/NR2B-antagonister | |
BRPI0512974A (pt) | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas | |
MXPA04005209A (es) | Antagonistas del receptor de adenosina a2a. | |
NO20052698L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser. | |
NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
SE0100569D0 (sv) | New compounds | |
MXPA04005156A (es) | Antagonistas del receptor de adenosina a2a. | |
NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
NO20052699L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
SE0104331D0 (sv) | Novel compounds | |
BR9910899A (pt) | Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida | |
SE0100566D0 (sv) | Compounds | |
SE9903894D0 (sv) | Novel compounds | |
NO20052172D0 (no) | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |